Comparing the expression levels of genes in BHLHE40 KD SAL-treated samples with those of their paired controls revealed a reduction in the ‘cellular senescence’, an induction in the ‘PI3K/AKT signaling in cancer’, and a reduction in the ‘circadian clock’ pathways (Fig. 3H). The gene discussed is BHLHE40; the disease is cancer.